Drugs / Linzhi Jianghuang Fufang Huoxue Anshen Capsule
Linzhi Jianghuang Fufang Huoxue Anshen Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07637006 | Sep 2026 → Jul 2028 expected | metabolic dysfunction-associated steatotic liver disease | Hong Kong Baptist University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Linzhi Jianghuang Fufang Huoxue Anshen Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07637006 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “is composed of five herbs” NCT07637006 ↗ |
| Route | Oral | “receive oral LJF capsules, 3 capsules per dose (0.4 g per capsule; total 1.2 g), administered twice daily for a duration of 24 weeks.” NCT07637006 ↗ |